Blog
.jpeg)
DAPASUG-VM-500 Tablets: Triple-Action Therapy for Advanced Type 2 Diabetes Management
- 19-02-2026
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disorder characterized by insulin resistance, impaired insulin secretion, and increased hepatic glucose production. When blood sugar levels are not adequately controlled with dual therapy, patients require a more comprehensive approach that targets multiple pathophysiological mechanisms simultaneously.
DAPASUG-VM-500 Tablets combine Dapagliflozin 10 mg + Vildagliptin 100 mg + Metformin Hydrochloride IP 500 mg (SR) in a single formulation, offering triple-action glycemic control for adults with inadequately controlled Type 2 Diabetes.
Understanding the Composition of DAPASUG-VM-500 Tablets
Dapagliflozin 10 mg – SGLT2 Inhibitor
Dapagliflozin works by inhibiting the Sodium-Glucose Co-Transporter-2 (SGLT2) in the kidneys, promoting glucose excretion through urine.
Key benefits of Dapagliflozin:
? Promotes urinary glucose excretion
? Reduces fasting and postprandial glucose levels
? Supports weight management
? Provides cardiovascular and renal benefits (as clinically established)
Vildagliptin 100 mg – DPP-4 Inhibitor
Vildagliptin enhances incretin hormone activity, improving insulin secretion and reducing glucagon release in a glucose-dependent manner.
Key benefits of Vildagliptin:
? Enhances insulin release
? Reduces inappropriate glucagon secretion
? Improves post-meal blood sugar control
? Low risk of hypoglycemia
Metformin Hydrochloride IP 500 mg (SR) – Insulin Sensitizer
Metformin (Sustained Release) reduces hepatic glucose production and improves peripheral insulin sensitivity.
Key benefits of Metformin SR:
? Decreases liver glucose output
? Improves insulin sensitivity
? Supports long-term glycemic stability
? Sustained-release formulation enhances tolerability
Indications of DAPASUG-VM-500 Tablets
DAPASUG-VM-500 Tablets are indicated:
• For management of Type 2 Diabetes Mellitus in adults
• When blood glucose is not adequately controlled with dual therapy
• To improve glycemic control through multi-mechanism action
This triple-drug combination addresses insulin resistance, insulin deficiency, and excess glucose reabsorption simultaneously.
Why Choose DAPASUG-VM-500 Tablets?
1. Triple-Mechanism Glycemic Control
Targets three major pathways involved in Type 2 Diabetes.
2. Improved Treatment Compliance
Three antidiabetic agents in one convenient tablet.
3. Sustained Glucose Control
Metformin SR ensures steady glucose-lowering effect.
4. Reduced Risk of Hypoglycemia
Glucose-dependent insulin stimulation reduces sudden drops in sugar levels.
How DAPASUG-VM-500 Tablets Work
DAPASUG-VM-500 Tablets work by:
• Increasing urinary glucose excretion (Dapagliflozin)
• Enhancing insulin secretion & reducing glucagon (Vildagliptin)
• Improving insulin sensitivity & reducing hepatic glucose output (Metformin SR)
This synergistic mechanism ensures comprehensive blood sugar management.
Dosage and Administration
Dosage:
• As directed by the healthcare professional
Administration Guidelines:
• Swallow whole with water
• Do not crush or chew (SR formulation)
• Take preferably with meals or as advised
?? Regular blood glucose monitoring is recommended during therapy.
Packing Details
• Composition: Dapagliflozin 10 mg + Vildagliptin 100 mg + Metformin Hydrochloride IP 500 mg (SR)
• Packing: 10 × 10
• Dosage Form: Tablet
Possible Side Effects of DAPASUG-VM-500 Tablets
This medication is generally well tolerated. Possible side effects may include:
• Gastrointestinal discomfort
• Increased urination
• Mild urinary tract infections
• Headache
Consult a healthcare professional if symptoms persist.
Who Can Benefit from DAPASUG-VM-500 Tablets?
? Adults with Type 2 Diabetes inadequately controlled on dual therapy
? Patients requiring multi-mechanism glucose control
? Individuals needing improved glycemic stability
? Patients seeking convenient combination therapy
Why Healthcare Professionals Recommend DAPASUG-VM-500 Tablets
Healthcare professionals prefer DAPASUG-VM-500 Tablets because they:
• Provide comprehensive glycemic control
• Combine three evidence-based antidiabetic agents
• Improve treatment adherence
• Address multiple underlying mechanisms of diabetes
Conclusion: Advanced Glycemic Control with DAPASUG-VM-500 Tablets
If you are looking for:
? Better blood sugar management
? Triple-mechanism diabetes therapy
? Improved insulin function and glucose control
DAPASUG-VM-500 Tablets offer a clinically advanced approach to managing Type 2 Diabetes Mellitus effectively.